July 2026– date –
-
DexCom Expands Stelo Glucose Biosensor to Non-Insulin-Using Children, Launches Redesigned App in US July 2026
WealthMagik (via Earnings Stability Report) USA Overview DexCom announced FDA approval to expand the Stelo Glucose Biosensor to non-insulin-using children aged 2 and older, aligning with the company's mission to make glucose sensing more... -
ACS Publications Announces Low-Cost, Open-Source In Situ Near-Real-Time Sensor for Nitrate & Ammonia in Environmental Waters: Achieves R2 of 0.96 with Over 400 Stable Responses
ACS Publications USA Overview This research developed a low-cost, open-source, in situ, near-real-time sensor for detecting nitrate and ammonia in environmental waters. The colorimetric sensor achieved near-perfect accuracy with an R2 va... -
DLG Report Details Nanosensor Innovation in Food Industry: FluIDect for Real-time Quality Monitoring, Oxford Nanopore for Pathogen ID
DLG-Expert report Germany Overview According to a DLG expert report, nanosensors significantly enhance accuracy, sensitivity, and speed in food testing by detecting, quantifying, and monitoring chemical, physical, or biological parameter... -
ACS Applied Nano Materials Reviews Single-Atom Nanozymes: Drastically Improving Sensitivity and Specificity for Biomolecule and Pollutant Detection
ACS Applied Nano Materials USA Overview Single-atom nanozymes (SAzymes) significantly reduce detection limits (LOD) and improve detection sensitivity and specificity due to their highly efficient substrate catalysis. These properties pos... -
MDPI: Nanoparticle-Based Biosensors Redefine Biomedical Diagnostics and Environmental Monitoring, Enhancing Pathogenic Nucleic Acid Detection Sensitivity
MDPI Switzerland Overview According to an editorial in MDPI, nanoparticle-based biosensors are redefining the future of biomedical diagnostics and environmental monitoring. Diagnostic platforms leveraging nanoparticles have significantly... -
ACS Publications Unveils Multimodal Cell-Free Biosensing Platform for Highly Sensitive Detection of Lethal Mushroom Toxin α-Amanitin
ACS Publications USA Overview This research developed a transcription-based multimodal cell-free biosensing platform for highly sensitive detection of α-amanitin, a lethal mushroom toxin. The platform converts α-amanitin-dependent RNA po... -
Smartwatches Revolutionize Blood Sugar Management: Dexcom G7 and FreeStyle Libre Enhance Apple Watch Integration, Expanding AI-Driven Ecosystem
TechRepublic USA Overview Smartwatches hold the potential to transform glucose tracking, but current advancements rely on the integration of continuous glucose monitoring (CGM), artificial intelligence (AI), and regulated healthcare tech... -
China’s POMDOCTOR Pivots to AI-Driven Predictive Healthcare Platform, Integrating Wearables & Data for Enhanced Chronic Disease Management
Stock Titan China Overview China-based digital healthcare company POMDOCTOR announced a strategic pivot to an AI-driven predictive healthcare platform. The company plans to integrate wearable devices, artificial intelligence, physician r... -
July 2026 Digital Health Trends: AI Wearable Patch Hits 99.6% Arrhythmia Detection, Clair Health Secures $11.6M for Women’s Health Wearable
Digital Health Trends (Openloop Health blog) USA Overview June 2026 marked significant advancements in digital health. An AI wearable patch achieved 99.6% accuracy in detecting life-threatening arrhythmias, while Midjourney unveiled an u... -
RSC Publishing: Machine Learning-Augmented Lateral Flow Assays Dramatically Boost Sensitivity & Quantification in Infectious Disease POCT Diagnostics
Lab on a Chip (RSC Publishing) UK Overview Lateral Flow Assays (LFAs) are widely used as Point-of-Care (PoC) diagnostic platforms for infectious diseases due to their rapid operation, low cost, and user-friendly design. However, conventi...
